These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34492446)

  • 1. Effects of antibiotic duration on the intestinal microbiota and resistome: The PIRATE RESISTANCE project, a cohort study nested within a randomized trial.
    Leo S; Lazarevic V; von Dach E; Kaiser L; Prendki V; Schrenzel J; Huttner BD; Huttner A
    EBioMedicine; 2021 Sep; 71():103566. PubMed ID: 34492446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial.
    von Dach E; Albrich WC; Brunel AS; Prendki V; Cuvelier C; Flury D; Gayet-Ageron A; Huttner B; Kohler P; Lemmenmeier E; McCallin S; Rossel A; Harbarth S; Kaiser L; Bochud PY; Huttner A
    JAMA; 2020 Jun; 323(21):2160-2169. PubMed ID: 32484534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients With Cirrhosis.
    Shamsaddini A; Gillevet PM; Acharya C; Fagan A; Gavis E; Sikaroodi M; McGeorge S; Khoruts A; Albhaisi S; Fuchs M; Sterling RK; Bajaj JS
    Gastroenterology; 2021 Aug; 161(2):508-521.e7. PubMed ID: 33857456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia.
    Huttner A; Albrich WC; Bochud PY; Gayet-Ageron A; Rossel A; Dach EV; Harbarth S; Kaiser L
    BMJ Open; 2017 Jul; 7(7):e017996. PubMed ID: 28710229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short versus prolonged courses of antibiotic therapy for children with uncomplicated Gram-negative bacteraemia.
    Park SH; Milstone AM; Diener-West M; Nussenblatt V; Cosgrove SE; Tamma PD
    J Antimicrob Chemother; 2014 Mar; 69(3):779-85. PubMed ID: 24159153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cohort study in family triads: impact of gut microbiota composition and early life exposures on intestinal resistome during the first two years of life.
    Jokela R; Pärnänen KM; Ponsero AJ; Lahti L; Kolho KL; de Vos WM; Salonen A
    Gut Microbes; 2024; 16(1):2383746. PubMed ID: 39092808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How representative is a point-of-care randomized trial? Clinical outcomes of patients excluded from a point-of-care randomized controlled trial evaluating antibiotic duration for Gram-negative bacteraemia: a multicentre prospective observational cohort study.
    Rossel A; Zandberg KPM; Albrich WC; Huttner A
    Clin Microbiol Infect; 2022 Feb; 28(2):297.e1-297.e6. PubMed ID: 34116204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistomes of healthy pig faecal metagenomes.
    Joyce A; McCarthy CGP; Murphy S; Walsh F
    Microb Genom; 2019 May; 5(5):. PubMed ID: 31091181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion and persistence of antibiotic-specific resistance genes following antibiotic treatment.
    Kang K; Imamovic L; Misiakou MA; Bornakke Sørensen M; Heshiki Y; Ni Y; Zheng T; Li J; Ellabaan MMH; Colomer-Lluch M; Rode AA; Bytzer P; Panagiotou G; Sommer MOA
    Gut Microbes; 2021; 13(1):1-19. PubMed ID: 33779498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.
    Buelow E; Bello González TDJ; Fuentes S; de Steenhuijsen Piters WAA; Lahti L; Bayjanov JR; Majoor EAM; Braat JC; van Mourik MSM; Oostdijk EAN; Willems RJL; Bonten MJM; van Passel MWJ; Smidt H; van Schaik W
    Microbiome; 2017 Aug; 5(1):88. PubMed ID: 28803549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Description and determinants of the faecal resistome and microbiome of farmers and slaughterhouse workers: A metagenome-wide cross-sectional study.
    Van Gompel L; Luiken REC; Hansen RB; Munk P; Bouwknegt M; Heres L; Greve GD; Scherpenisse P; Jongerius-Gortemaker BGM; Tersteeg-Zijderveld MHG; García-Cobos S; Dohmen W; Dorado-García A; Wagenaar JA; Urlings BAP; Aarestrup FM; Mevius DJ; Heederik DJJ; Schmitt H; Bossers A; Smit LAM
    Environ Int; 2020 Oct; 143():105939. PubMed ID: 32679392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial.
    Yahav D; Franceschini E; Koppel F; Turjeman A; Babich T; Bitterman R; Neuberger A; Ghanem-Zoubi N; Santoro A; Eliakim-Raz N; Pertzov B; Steinmetz T; Stern A; Dickstein Y; Maroun E; Zayyad H; Bishara J; Alon D; Edel Y; Goldberg E; Venturelli C; Mussini C; Leibovici L; Paul M;
    Clin Infect Dis; 2019 Sep; 69(7):1091-1098. PubMed ID: 30535100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominantly Antibiotic-resistant Intestinal Microbiome Persists in Patients With Pouchitis Who Respond to Antibiotic Therapy.
    Dubinsky V; Reshef L; Bar N; Keizer D; Golan N; Rabinowitz K; Godny L; Yadgar K; Zonensain K; Tulchinsky H; Gophna U; Dotan I
    Gastroenterology; 2020 Feb; 158(3):610-624.e13. PubMed ID: 31605691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal assessment of antibiotic resistance gene profiles in gut microbiomes of infants at risk of eczema.
    Loo EXL; Zain A; Yap GC; Purbojati RW; Drautz-Moses DI; Koh YQ; Chong YS; Tan KH; Gluckman PD; Yap F; Eriksson JG; Tham E; Shek LP; Kjelleberg S; Schuster SC; Banerjee R; Lee BW
    BMC Infect Dis; 2020 Apr; 20(1):312. PubMed ID: 32345218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistome expansion in disease-associated human gut microbiomes.
    Fredriksen S; de Warle S; van Baarlen P; Boekhorst J; Wells JM
    Microbiome; 2023 Jul; 11(1):166. PubMed ID: 37507809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of investigational microbiota therapeutic RBX2660 on the gut microbiome and resistome revealed by a placebo-controlled clinical trial.
    Kwak S; Choi J; Hink T; Reske KA; Blount K; Jones C; Bost MH; Sun X; Burnham CD; Dubberke ER; Dantas G;
    Microbiome; 2020 Aug; 8(1):125. PubMed ID: 32862830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent impact of oxytetracycline on the veal calf microbiome and resistome.
    Keijser BJF; Agamennone V; van den Broek TJ; Caspers M; van de Braak A; Bomers R; Havekes M; Schoen E; van Baak M; Mioch D; Bomers L; Montijn RC
    BMC Genomics; 2019 Jan; 20(1):65. PubMed ID: 30660184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Respiratory Resistomes and Microbiota in Children Receiving Short versus Standard Course Treatment for Community-Acquired Pneumonia.
    Pettigrew MM; Kwon J; Gent JF; Kong Y; Wade M; Williams DJ; Creech CB; Evans S; Pan Q; Walter EB; Martin JM; Gerber JS; Newland JG; Hofto ME; Staat MA; Fowler VG; Chambers HF; Huskins WC;
    mBio; 2022 Apr; 13(2):e0019522. PubMed ID: 35323040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct impact of antibiotics on the gut microbiome and resistome: a longitudinal multicenter cohort study.
    Willmann M; Vehreschild MJGT; Biehl LM; Vogel W; Dörfel D; Hamprecht A; Seifert H; Autenrieth IB; Peter S
    BMC Biol; 2019 Sep; 17(1):76. PubMed ID: 31533707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.